GHRP-2
GHRP-2
Also known as: Pralmorelin, KP-102, D-Ala-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2
Overview
Key Facts
Primary Goal: A synthetic hexapeptide GH secretagogue considered the most potent in the GHRP family
A synthetic hexapeptide GH secretagogue considered the most potent in the GHRP family. It produces strong GH release through the ghrelin receptor with moderate effects on appetite, cortisol, and prolactin, falling between GHRP-6 and ipamorelin in selectivity. Half-Life 15-60 minutes Typical Dose 100–300 mcg Frequency 2-3 times daily Cycle Length 8-16 weeks
Dosing Information
Half-Life
15-60 minutes
Typical Dose
100–300 mcg
Frequency
2-3 times daily
Cycle Length
8-16 weeks
Administration Routes:
Storage & Reconstitution
Unreconstituted (Powder)
Reconstituted (Mixed)
Note: Protect from light. Do not freeze reconstituted solution.
Research Summary
GHRP-2 (Pralmorelin) has been approved in Japan as a diagnostic agent for GH deficiency and extensively studied in clinical settings. Research demonstrates it produces the highest peak GH levels among GHRPs, approximately 20-40% greater than GHRP-6. Studies also suggest neuroprotective effects in models of neurodegeneration.
Frequently Asked Questions
Common questions about GHRP-2
UK-Specific Information
Exclusive data points and guidance for UK residents using GHRP-2
UK Lab Testing
US Lab Testing
Recommended labs: Quest Diagnostics, LabCorp ($120-$200 for peptide safety panel)
Why this matters: UK-specific lab testing guidance not available on US competitor sites
Commonly Stacked With
5-Amino-1MQ
Research and therapeutic applications of 5-Amino-1MQ
Ac-SDKP
Research and therapeutic applications of Ac-SDKP
ACE-031
Research and therapeutic applications of ACE-031
Acetyl Hexapeptide-3
Research and therapeutic applications of Acetyl Hexapeptide-3
AHK-Cu
Research and therapeutic applications of AHK-Cu
Alcohol Prep Pads
Research and therapeutic applications of Alcohol Prep Pads
Note: Peptide stacking should only be done under the guidance of a qualified healthcare professional. Individual responses may vary.